Sublethal streptomycin concentrations and lytic bacteriophage together promote resistance evolution

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 372, Issue 1712, 2017, Pages

  Cairns, Johannes ^a   Becks, Lutz ^b   Jalasvuori, Matti ^c   Hiltunen, Teppo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

^c UNIVERSITY OF JYVÄSKYLÄ   (Finland)

Author keywords

Antibiotic resistance; Experimental evolution; Phage resistance; Phage 2; Pseudomonas fluorescens; Sublethal antibiotic concentrations

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIOPHAGE; CONCENTRATION (COMPOSITION); EVOLUTIONARY BIOLOGY; FITNESS; MICROBIAL COMMUNITY; SUBLETHAL EFFECT;

BACTERIA (MICROORGANISMS); PSEUDOMONAS FLUORESCENS;

ANTIINFECTIVE AGENT; STREPTOMYCIN;

DRUG EFFECTS; EVOLUTION; GENETICS; MOLECULAR EVOLUTION; PHYSIOLOGY; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PHAGE; VIROLOGY;

ANTI-BACTERIAL AGENTS; BIOLOGICAL EVOLUTION; EVOLUTION, MOLECULAR; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS PHAGES; STREPTOMYCIN;

EID: 85006022116     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2016.0040     Document Type: Article

References (73)

1. Levy SB, Marshall B. 2004 Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122-S129. (doi:10.1038/nm1145)
2. Meaden S, Koskella B. 2013 Exploring the risks of phage application in the environment. Front. Microbiol. 4, 358. (doi:10.3389/fmicb.2013.00358)
3. Rodríguez-Rojas A, Rodríguez-Beltrán J, Couce A, Blázquez J. 2013 Antibiotics and antibiotic resistance: a bitter fight against evolution. Int. J. Med. Microbiol. 303, 293-297. (doi:10.1016/j.ijmm.2013.02.004)
4. Rogalski MA, Gowler CD, Shaw CL, Hufbauer RA, Duffy MA. 2017 Human drivers of ecological and evolutionary dynamics in emerging and disappearing infectious disease systems. Phil. Trans. R. Soc. B 372, 20160043. (doi:10.1098/rstb.2016.0043)
5. Hiltunen T, Virta M, Laine A-L. 2017 Antibiotic resistance in the wild: an eco-evolutionary perspective. Phil. Trans. R. Soc. B 372, 20160039. (doi:10.1098/rstb.2016.0039)
6. Turcotte MM, Araki H, Karp DS, Poveda K, Whitehead SR. 2017 The eco-evolutionary impacts of domestication and agricultural practices on wild species. Phil. Trans. R. Soc. B 372, 20160033. (doi:10.1098/rstb.2016.0033)
7. Andersson DI, Hughes D. 2014 Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12, 465-478. (doi:10.1038/nrmicro3270)
8. Andersson DI, Hughes D. 2012 Evolution of antibiotic resistance at non-lethal drug concentrations. Drug Resist. Updat. 15, 162-172. (doi:10.1016/j.drup.2012.03.005)
9. Perron GG, Gonzalez A, Buckling A. 2007 Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. Proc. R. Soc. B 274, 2351-2356. (doi:10.1098/rspb.2007.0640)
10. Benmayor R, Hodgson DJ, Perron GG, Buckling A. 2009 Host mixing and disease emergence. Curr. Biol. 19, 764-767. (doi:10.1016/j.cub.2009.03.023)
11. Henderson-Begg SK, Livermore DM, Hall LM. 2006 Effect of subinhibitory concentrations of antibiotics on mutation frequency in Streptococcus pneumoniae. J. Antimicrob. Chemother. 57, 849-854. (doi:10.1093/jac/dkl064)
12. Wu YL, Scott EM, Po AL, Tariq VN. 1999 Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations. APMIS 107, 585-592. (doi:10.1111/j.1699-0463.1999.tb01596.x)
13. Baharoglu Z, Mazel D. 2011 Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance. Antimicrob. Agents Chemother. 55, 2438-2441. (doi:10.1128/AAC.01549-10)
14. Kohanski MA, DePristo MA, Collins JJ. 2010 Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol. Cell. 37, 311-320. (doi:10.1016/j.molcel.2010.01.003)
15. Nagel M, Reuter T, Jansen A, Szekat C, Bierbaum G. 2011 Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus. Int. J. Med. Microbiol. 301, 229-236. (doi:10.1016/j.ijmm.2010.08.021)
16. Gutierrez A et al. 2013 b-Lactam antibiotics promote bacterial mutagenesis via an RpoSmediated reduction in replication fidelity. Nat. Commun. 4, 1610. (doi:10.1038/ncomms2607)
17. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP. 2006 Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 313, 89-92. (doi:10.1126/science.1127912)
18. Beaber JW, Hochhut B, Waldor MK. 2004 SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 427, 72-74. (doi:10.1038/nature02241)
19. López E, Blázquez J. 2009 Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli. Antimicrob. Agents Chemother. 53, 3411-3415. (doi:10.1128/AAC.00358-09)
20. Nalca Y, Jänsch L, Bredenbruch F, Geffers R, Buer J, Häussler S. 2006 Quorum-sensing antagonistic activities of azithromycin in Pseudomonas aeruginosa PAO1: a global approach. Antimicrob. Agents Chemother. 50, 1680-1688. (doi:10.1128/AAC.50.5.1680-1688.2006)
21. Li D, Renzoni A, Estoppey T, Bisognano C, Francois P, Kelley WL, Lew DP, Schrenzel J, Vaudaux P. 2005 Induction of fibronectin adhesins in quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin or by sigma B transcription factor activity is mediated by two separate pathways. Antimicrob. Agents Chemother. 49, 916-924. (doi:10.1128/AAC.49.3.916-924.2005)
22. Otto MP, Martin E, Badiou C, Lebrun S, Bes M, Vandenesch F, Etienne J, Lina G, Dumitrescu O. 2013 Effects of subinhibitory concentrations of antibiotics on virulence factor expression by communityacquired methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 68, 1524-1532. (doi:10.1093/jac/dkt073)
23. Knudsen GM, Holch A, Gram L. 2012 Subinhibitory concentrations of antibiotics affect stress and virulence gene expression in Listeria monocytogenes and cause enhanced stress sensitivity but do not affect Caco-2 cell invasion. J. Appl. Microbiol. 113, 1273-1286. (doi:10.1111/j.1365-2672.2012.05435.x)
24. Clokie MR, Millard AD, Letarov AV, Heaphy S. 2011 Phages in nature. Bacteriophage 1, 31-45. (doi:10.4161/bact.1.1.14942)
25. Gómez P, Buckling A. 2011 Bacteria-phage antagonistic coevolution in soil. Science 332, 106-109. (doi:10.1126/science.1198767)
26. Koskella B, Brockhurst MA. 2014 Bacteria-phage coevolution as a driver of ecological and evolutionary processes in microbial communities. FEMS Microbiol. Rev. 38, 916-931. (doi:10.1111/1574-6976.12072)
27. Hall AR, De Vos D, Friman VP, Pirnay JP, Buckling A. 2012 Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae. Appl. Environ. Microbiol. 78, 5646-5652. (doi:10.1128/AEM.00757-12)
28. Buckling A, Wei Y, Massey RC, Brockhurst MA, Hochberg ME. 2006 Antagonistic coevolution with parasites increases the cost of host deleterious mutations. Proc. R. Soc. B 273, 45-49. (doi:10.1098/rspb.2005.3279)
29. Brockhurst MA, Morgan AD, Fenton A, Buckling A. 2007 Experimental coevolution with bacteria and phage. The Pseudomonas fluorescens—F2 model system. Infect. Genet. Evol. 7, 547-552. (doi:10.1016/j.meegid.2007.01.005)
30. Andersson DI. 2006 The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol. 9, 461-465. (doi:10.1016/j.mib.2006.07.002)
31. MacLean RC, Hall AR, Perron GG, Buckling A. 2010 The population genetics of antibiotic resistance: integrating molecular mechanisms and treatment contexts. Nat. Rev. Genet. 11, 405-414. (doi:10. 1038/nrg2778)
32. Andersson DI, Hughes D. 2011 Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol. Rev. 35, 901-911. (doi:10.1111/j.1574-6976.2011.00289.x)
33. Loc-Carrillo C, Abedon ST. 2011 Pros and cons of phage therapy. Bacteriophage 1, 111-114. (doi:10.4161/bact.1.2.14590)
34. Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST. 2010 Phage therapy in clinical practice: treatment of human infections. Curr. Pharm. Biotechnol. 11, 69-86. (doi:10.2174/138920110790725401)
35. Alisky J, Iczkowski K, Rapoport A, Troitsky N. 1998 Bacteriophages show promise as antimicrobial agents. J. Infect. 36, 5-15. (doi:10.1016/S0163-4453(98)92874-2)
36. Zhang QG. 2014 Exposure to phages has little impact on the evolution of bacterial antibiotic resistance on drug concentration gradients. Evol. Appl. 7, 394-402. (doi:10.1111/eva.12136)
37. Torres-Barceló C, Arias-Sánchez FI, Vasse M, Ramsayer J, Kaltz O, Hochberg ME. 2014 A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages. PLoS ONE 9, e106628. (doi:10.1371/journal.pone.0106628)
38. Bourguet D, Delmotte F, Franck P, Guillemaud T, Reboud X, Vacher C, Walker AS. 2013 Heterogeneity of selection and the evolution of resistance. Trends Ecol. Evol. 28, 110-118. (doi:10.1016/j.tree.2012.09.001)
39. Ward H, Perron GG, Maclean RC. 2009 The cost of multiple drug resistance in Pseudomonas aeruginosa. J. Evol. Biol. 22, 997-1003. (doi:10.1111/j.1420-9101.2009.01712.x)
40. Levin BR, Bull JJ. 1996 Phage therapy revisited: the population biology of a bacterial infection and its treatment with bacteriophage and antibiotics. Am. Nat. 147, 881-898. (doi:10.1086/285884)
41. Tazzyman SJ, Hall AR. 2015 Lytic phages obscure the cost of antibiotic resistance in Escherichia coli. ISME J. 9, 809-820. (doi:10.1038/ismej.2014.176)
42. Rainey PB, Bailey MJ. 1996 Physical and genetic map of the Pseudomonas fluorescens SBW25 chromosome. Mol. Microbiol. 19, 521-533. (doi:10.1046/j.1365-2958.1996.391926.x)
43. Buckling A, Rainey PB. 2002 Antagonistic coevolution between a bacterium and a bacteriophage. Proc. R. Soc. Lond. B 269, 931-936. (doi:10.1098/rspb.2001.1945)
44. Hiltunen T, Becks L. 2014 Consumer co-evolution as an important component of the eco-evolutionary feedback. Nat. Commun. 5, 5226. (doi:10.1038/ncomms6226)
45. Hiltunen T, Ayan GB, Becks L. 2015 Environmental fluctuations restrict eco-evolutionary dynamics in predator-prey system. Proc. R. Soc. B 282, 20150013. (doi:10.1098/rspb.2015.0013)
46. Brockhurst MA, Morgan AD, Rainey PB, Buckling A. 2003 Population mixing accelerates coevolution. Ecol. Lett. 6, 975-979. (doi:10.1046/j.1461-0248.2003.00531.x)
47. Brockhurst MA, Rainey PB, Buckling A. 2004 The effect of spatial heterogeneity and parasites on the evolution of host diversity. Proc. R. Soc. Lond. B 271, 107-111. (doi:10.1098/rspb.2003.2556)
48. Kassen R, Buckling A, Bell G, Rainey PB. 2000 Diversity peaks at intermediate productivity in a laboratory microcosm. Nature 406, 508-512. (doi:10.1038/35020060)
49. Rainey PB, Travisano M. 1998 Adaptive radiation in a heterogeneous environment. Nature 394, 69-72. (doi:10.1038/27900)
50. Friman VP, Buckling A. 2013 Effects of predation on real-time host-parasite coevolutionary dynamics. Ecol. Lett. 16, 39-46. (doi:10.1111/ele.12010)
51. Hall AR, Scanlan PD, Morgan AD, Buckling A. 2011 Host-parasite coevolutionary arms races give way to fluctuating selection. Ecol. Lett. 14, 635-642. (doi:10.1111/j.1461-0248.2011.01624.x)
52. Harrison E, Wood AJ, Dytham C, Pitchford JW, Truman J, Spiers A, Paterson S, Brockhurst MA. 2015 Bacteriophages limit the existence conditions for conjugative plasmids. mBio 6, e00586. (doi:10.1128/mBio.00586-15)
53. Scanlan PD, Buckling A. 2012 Co-evolution with lytic phage selects for the mucoid phenotype of Pseudomonas fluorescens SBW25. ISME J. 6, 1148-1158. (doi:10.1038/ismej.2011.174)
54. Morgan AD, Gandon S, Buckling A. 2005 The effect of migration on local adaptation in a coevolving host-parasite system. Nature 437, 253-256. (doi:10.1038/nature03913)
55. Duetz WA, Rüedi L, Hermann R, O’Connor K, Büchs J, Witholt B. 2000 Methods for intense aeration, growth, storage, and replication of bacterial strains in microtiter plates. Appl. Environ. Microbiol. 66, 2641-2646. (doi:10.1128/AEM.66.6.2641-2646.2000)
56. Pal C, Maciá MD, Oliver A, Schachar I, Buckling A. 2007 Coevolution with viruses drives the evolution of bacterial mutation rates. Nature 450, 1079-1081. (doi:10.1038/nature06350)
57. Scanlan PD, Hall AR, Blackshields G, Friman VP, Davis Jr MR, Goldberg JB, Buckling A. 2015 Coevolution with bacteriophages drives genomewide host evolution and constrains the acquisition of abiotic-beneficial mutations. Mol. Biol. Evol. 32, 1425-1435. (doi:10.1093/molbev/msv032)
58. Hall BM, Ma CX, Liang P, Singh KK. 2009 Fluctuation analysis CalculatOR: a web tool for the determination of mutation rate using Luria-Delbruck fluctuation analysis. Bioinformatics 25, 1564-1565. (doi:10.1093/bioinformatics/btp253)
59. R Core Team. 2015 R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
60. Bates D, Maechler M, Bolker B, Walker S. 2015 Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1-48. (doi:10.18637/jss.v067.i01)
61. Rosche WA, Foster PL. 2000 Determining mutation rates in bacterial populations. Methods 20, 4-17. (doi:10.1006/meth.1999.0901)
62. Heiberger RM. 2016 HH: Statistical analysis and data display: Heiberger and Holland. R package version 3. 1-25. See http://CRAN.R-project.org/package=HH.
63. Boe L. 1992 Translational errors as the cause of mutations in Escherichia coli. Mol. Gen. Genet. 231, 469-471. (doi:10.1007/BF00292717)
64. Ren L, Rahman MS, Humayun MZ. 1999 Escherichia coli cells exposed to streptomycin display a mutator phenotype. J. Bacteriol. 181, 1043-1044.
65. Nagel R, Chan A. 2006 Mistranslation and genetic variability: the effect of streptomycin. Mutat. Res. 601, 162-170. (doi:10.1016/j.mrfmmm.2006.06.012)
66. O’Brien S, Rodrigues AM, Buckling A. 2013 The evolution of bacterial mutation rates under simultaneous selection by interspecific and social parasitism. Proc. R. Soc. B 280, 20131913. (doi:10.1098/rspb.2013.1913)
67. Escobar-Páramo P, Gougat-Barbera C, Hochberg ME. 2012 Evolutionary dynamics of separate and combined exposure of Pseudomonas fluorescens SBW25 to antibiotics and bacteriophage. Evol. Appl. 5, 583-592. (doi:10.1111/j.1752-4571.2012.00248.x)
68. Zhang QG, Buckling A. 2012 Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms. Evol. Appl. 5, 575-582. (doi:10.1111/j.1752-4571.2011.00236.x)
69. Brock TD. 1962 The inhibition of an RNA bacteriophage by streptomycin, using host bacteria resistant to the antibiotic. Biochem. Biophys. Res. Commun. 9, 184-187. (doi:10.1016/0006-291X(62)90111-0)
70. Brock TD, Mosser J, Peacher B. 1963 The inhibition by streptomycin of certain Streptococcus bacteriophages, using host bacteria resistant to the antibiotic. J. Gen. Microbiol. 33, 9-22. (doi:10. 1099/00221287-33-1-9)
71. Schindler J. 1964 Inhibition of reproduction of the f2 bacteriophage by streptomycin. Folia Microbiol. (Praha) 89, 269-276. (doi:10.1007/BF02873305)
72. Coulter LB, McLean RJ, Rohde RE, Aron GM. 2014 Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms. Viruses 6, 3778-3786. (doi:10.3390/v6103778)
73. Kirby AE. 2012 Synergistic action of gentamicin and bacteriophage in a continuous culture population of Staphylococcus aureus. PLoS ONE 7, e51017. (doi:10.1371/journal.pone.0051017)